These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A systematic review of microstructural abnormalities in multiple sclerosis detected with NODDI and DTI models of diffusion-weighted magnetic resonance imaging. Caranova M, Soares JF, Batista S, Castelo-Branco M, Duarte JV. Magn Reson Imaging; 2023 Dec; 104():61-71. PubMed ID: 37775062 [Abstract] [Full Text] [Related]
9. Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study. Preziosa P, Rocca MA, Pagani E, Stromillo ML, Enzinger C, Gallo A, Hulst HE, Atzori M, Pareto D, Riccitelli GC, Copetti M, De Stefano N, Fazekas F, Bisecco A, Barkhof F, Yousry TA, Arévalo MJ, Filippi M, MAGNIMS Study Group. Hum Brain Mapp; 2016 Apr; 37(4):1627-44. PubMed ID: 26833969 [Abstract] [Full Text] [Related]
10. Comparison of diffusion tensor imaging (DTI) tissue characterization parameters in white matter tracts of patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). Chen X, Roberts N, Zheng Q, Peng Y, Han Y, Luo Q, Feng J, Luo T, Li Y. Eur Radiol; 2024 Aug; 34(8):5263-5275. PubMed ID: 38175221 [Abstract] [Full Text] [Related]
11. In vivo quantification of brain soma and neurite density abnormalities in multiple sclerosis. Margoni M, Pagani E, Preziosa P, Palombo M, Gueye M, Azzimonti M, Filippi M, Rocca MA. J Neurol; 2023 Jan; 270(1):433-445. PubMed ID: 36153468 [Abstract] [Full Text] [Related]
13. Application of neurite orientation dispersion and density imaging to characterize brain microstructural abnormalities in type-2 diabetics with mild cognitive impairment. Xiong Y, Zhang S, Shi J, Fan Y, Zhang Q, Zhu W. J Magn Reson Imaging; 2019 Sep; 50(3):889-898. PubMed ID: 30779402 [Abstract] [Full Text] [Related]
15. Cognitive impairment in early MS: contribution of white matter lesions, deep grey matter atrophy, and cortical atrophy. Engl C, Tiemann L, Grahl S, Bussas M, Schmidt P, Pongratz V, Berthele A, Beer A, Gaser C, Kirschke JS, Zimmer C, Hemmer B, Mühlau M. J Neurol; 2020 Aug; 267(8):2307-2318. PubMed ID: 32328718 [Abstract] [Full Text] [Related]
16. Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis. Xiang B, Wen J, Cross AH, Yablonskiy DA. J Magn Reson Imaging; 2019 Feb; 49(2):487-498. PubMed ID: 30155934 [Abstract] [Full Text] [Related]
17. Functional and structural brain MRI changes associated with cognitive worsening in multiple sclerosis: a 3-year longitudinal study. Azzimonti M, Preziosa P, Pagani E, Valsasina P, Tedone N, Vizzino C, Rocca MA, Filippi M. J Neurol; 2023 Sep; 270(9):4296-4308. PubMed ID: 37202603 [Abstract] [Full Text] [Related]
18. Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5-year study. Preziosa P, Pagani E, Mesaros S, Riccitelli GC, Dackovic J, Drulovic J, Filippi M, Rocca MA. Hum Brain Mapp; 2017 Nov; 38(11):5648-5665. PubMed ID: 28792103 [Abstract] [Full Text] [Related]
19. Impaired cognition is related to microstructural integrity in relapsing remitting multiple sclerosis. Zhao L, Ng A, Chen Q, Lam B, Abrigo J, Au C, Mok VCT, Wong A, Lau AY. Ann Clin Transl Neurol; 2020 Jul; 7(7):1193-1203. PubMed ID: 32519512 [Abstract] [Full Text] [Related]
20. Quantification of normal-appearing white matter damage in early relapse-onset multiple sclerosis through neurite orientation dispersion and density imaging. Margoni M, Villani U, Silvestri E, Franciotta S, Anglani MG, Causin F, Rinaldi F, Perini P, Bertoldo A, Gallo P. Mult Scler Relat Disord; 2022 Feb; 58():103396. PubMed ID: 35216779 [Abstract] [Full Text] [Related] Page: [Next] [New Search]